Peginterferon Lambda for the Treatment of Outpatients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Peginterferon Lambda for the Treatment of Outpatients With COVID-19: A Phase 2, Placebo-Controlled Randomised Trial
Lancet Respir Med 2021 Feb 05;[EPub Ahead of Print], JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, SM Borgia, AK Boggild, J Powis, J McCready, DHS Tan, T Chan, B Coburn, D Kumar, A Humar, A Chan, B O'Neil, S Noureldin, J Booth, R Hong, D Smookler, W Aleyadeh, A Patel, B Barber, J Casey, R Hiebert, H Mistry, I Choong, C Hislop, DM Santer, D Lorne Tyrrell, JS Glenn, AJ Gehring, HLA Janssen, BE HansenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.